Particle.news

Download on the App Store

ProKidney Surges 515%, Nvidia Tops $4 Trillion as Stocks Rise

Corporate updates in biotech, artificial intelligence partnerships, restructuring moves set the tone with the S&P 500 hovering near record levels

The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto, Ontario, Canada January 23, 2019.   REUTERS/Chris Helgren/File Photo
Image
A currency trader watches monitors near a screen showing the Korea Composite Stock Price Index (KOSPI), top center left, and the foreign exchange rate between U.S. dollar and South Korean won, top center, at the foreign exchange dealing room of the Hana Bank headquarters in Seoul, South Korea, Wednesday, July 9, 2025. (AP Photo/Ahn Young-joon)
Image

Overview

  • ProKidney shares jumped 515% after revealing positive Phase 2 REGEN-007 trial results for chronic kidney disease and diabetes.
  • SoundHound AI rallied nearly 12% despite a year-to-date drop of over 35%, as investors responded to renewed confidence following Nvidia’s exit.
  • QuantumScape posted a 16.7% gain in a delayed reaction to a late June production update on next-generation solid-state EV batteries.
  • Intel climbed 7.2% after Citigroup raised its price target and investors cheered the company’s global restructuring plans.
  • Traders awaited Federal Reserve minutes as Nvidia rose 1.1%, briefly topping a $4 trillion market cap on news of a deepened OpenAI partnership.